RxDoctor Payments Data

Hassan Rastegar, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Boston, MANPI 1982735155

Payments from drug & device makers

$9,690in general payments, 2019–2025

Across 108 payments — averaging $89.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$8K
  • Edwards Lifesciences$1K
  • Boehringer Ingelheim$78
  • AstraZeneca$62
  • Johnson & Johnson$42
  • Abbott$25
  • plus $50 from 3 others

What the payments were for

  • Consulting fees$1,12512%
  • Speaking & faculty fees$1,20012%
  • Travel & lodging$1,43015%
  • Food & beverage$5,93561%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)93$8,101
Edwards Lifesciences2$1,331
Boehringer Ingelheim3$78
AstraZeneca4$62
Johnson & Johnson2$42
Abbott1$25
Amgen1$20
Opsens Inc.1$16
Novartis1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,690 in reported general payments places this provider in the 60th percentile of 171 thoracic surgery (cardiothoracic vascular surgery) providers in Massachusetts.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Massachusetts

Medicare billing

Part B allowed, 2024
$109,165
Medicare patients
130
Services billed
138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →